Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Shane Foo

Senior Research Fellow

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Articles (8)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (5)

Lillian Wu

Institute of Cancer Research

UNITED KINGDOM

View details

Masahiro Ono

Professor

Imperial College London

UNITED KINGDOM

View details

Elizabeth Appleton

Speciality Registrar

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Antonio José Rullán

University College London

UNITED KINGDOM

View details

Dragomir Krastev

Institute of Cancer Research

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shane Foo

Research Interests

Explore related searches

Articles (8)

Addition of chemotherapy to radiotherapy promotes progenitor-exhausted CD8⁺ T-cell clonal dominance in head and neck cancer

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity

Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models

PBRM1 directs PBAF to pericentromeres and protects centromere integrity

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling.

Collaborators (5)

Lillian Wu

Masahiro Ono

Elizabeth Appleton

Antonio José Rullán

Dragomir Krastev

Make your next move.